Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris. (Q52020185)

19 April 2018

title

Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris. (English)

1 reference

19 April 2018

1 reference

1 reference

2

1 reference

19 April 2018

Paul Hjemdahl

series ordinal

4

1 reference

19 April 2018

author name string

Wallén NH

series ordinal

1

1 reference

19 April 2018

Rehnqvist N

series ordinal

3

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 January 1995

1 reference

19 April 2018

American Journal of Cardiology

published in

1 reference

19 April 2018

volume

75

1 reference

19 April 2018

issue

1

1 reference

19 April 2018

page(s)

1-6

1 reference

19 April 2018

Are we mortgaging the medical profession?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Physical exertion as a trigger of acute myocardial infarction. Triggers and Mechanisms of Myocardial Infarction Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Sudden cardiac death. Support for a role of triggering in causation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Catecholamine excretion as related to cognitive and emotional reaction patterns.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Altered platelet function during mental stress and adrenaline infusion in humans: evidence for an increased aggregability in vivo as measured by filtragometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

On the accurate determination of serotonin in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Impact of treatment with acetylsalicylic acid on the proaggregatory effects of adrenaline in vitro in patients with stable angina pectoris: influence of the anticoagulant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Oral verapamil inhibits platelet thrombus formation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Dose-dependent effects of verapamil and nifedipine on in vivo platelet function in normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Effects of calcium channel blockers on platelet aggregation and thromboxane A2 formation: an in vivo double blind randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Influence of a single dose of calcium channel blockers on platelet function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Verapamil, an antagonist at 5-hydroxytryptamine receptors of human blood platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Inhibition of platelet-activating factor binding to human platelets by calcium channel blockers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Inhibition of human platelet aggregation and cytoplasmic calcium response by calcium antagonists: studies with aequorin and quin2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Adenosine potentiates the inhibitory effects of calcium channel antagonists on human platelet aggregation induced by thromboxane A2 or U46619.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Widening potential for Ca2+ antagonists: non-L-type Ca2+ channel interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

The peripheral platelet count and ADP-induced platelet aggregation in response to metoprolol and propranolol as studied in young healthy male volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Suppression of silent ischemia by metoprolol without alteration of morning increase of platelet aggregability in patients with stable coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Exercise-induced platelet aggregation in angina and its possible prevention by beta 1-selective blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980516-5

10.1016/S0002-9149(99)80516-5

7 January 2021

Identifiers

DOI

1 reference

19 April 2018

PubMed ID

7801853

1 reference

19 April 2018